Iovance Biotherapeutics
IOVA
IOVA
86 hedge funds and large institutions have $325M invested in Iovance Biotherapeutics in 2015 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 26 increasing their positions, 9 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
65% less call options, than puts
Call options by funds: $439K | Put options by funds: $1.25M
Holders
86
Holding in Top 10
3
Calls
$439K
Puts
$1.25M
Top Buyers
| 1 | +$15.4M | |
| 2 | +$10.9M | |
| 3 | +$9.13M | |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$8.21M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$7.21M |
Top Sellers
| 1 | -$25.5M | |
| 2 | -$2.42M | |
| 3 | -$642K | |
| 4 |
Goldman Sachs
New York
|
-$425K |
| 5 |
QSS
Quantitative Systematic Strategies
Ponte Vedra Beach,
Florida
|
-$416K |